castration-resistant prostate cancer

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

castration-resistant prostate cancer

Aug 1, 2024, 04:07 | Blog

EORTC-1333-GUCG/PEACE III trial has reached it's primary endpoint

María Natalia Gandur Quiroga shared a post on X: "Exciting news from EORTC! EORTC-1333-GUCG/PEACE III…

Jul 12, 2024, 16:05 | Insight

Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC

Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…

Apr 19, 2024, 20:03 | Insight

Piotr Wysocki: BRCA1/2 mutations represent a poor prognostic factor for mCRCP patients - underscoring the need to use PARPi as soon as possible

Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…

All: 3 Posts: 1 - 100

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

'

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

'

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

'

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

'

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023